{"id":"W2025338891","doi":"10.1182/blood-2013-01-466706","title":"A phase 3 study of gemtuzumab ozogamicin during induction and postconsolidation therapy in younger patients with acute myeloid leukemia","year":2013,"lang":"en","type":"article","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":633,"is_retracted":false,"has_abstract":true,"ca_institutions":"University of Toronto; Vancouver General Hospital","funders":"National Cancer Institute","keywords":"Gemtuzumab ozogamicin; Cytarabine; Medicine; Daunorubicin; Gastroenterology; Internal medicine; Randomization; Myeloid leukemia; Induction chemotherapy; Surgery; Randomized controlled trial; Leukemia; Chemotherapy; CD33","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001407163,0.0008956647,0.001909108,0.0002551375,0.0002998527,0.0004862941,0.0005646634,0.0009148167,0.001920619],"category_scores_gemma":[0.001060006,0.000277175,0.001286917,0.0003187465,0.0006318107,0.000496914,0.000332774,0.002314728,0.0003114604],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0006646076,"about_ca_system_score_gemma":0.00105243,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0006973227,"about_ca_topic_score_gemma":0.00211749,"domain_scores_codex":[0.9995578,0.0002586636,0.00002117589,0.00005453398,0.00003237799,0.00007538217],"domain_scores_gemma":[0.9990845,0.0001678699,0.0002325765,0.00005718576,0.00002945313,0.0004284068],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9036835,0.01939093,0.004393235,0.0003107957,0.0007759748,0.0001404395,0.0001021461,0.0009269549,0.01359338,0.0001574524,0.001146411,0.05537872],"study_design_scores_gemma":[0.6365184,0.3467739,0.01190037,0.0000224809,0.0003891524,0.0001720042,0.00002819242,0.0008388443,0.001674993,0.0001751682,0.001487646,0.00001875944],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9961809,0.001506804,0.0002569567,0.0002369326,0.00009906838,0.0009959323,0.0002259266,0.00003686526,0.0004606069],"genre_scores_gemma":[0.9932025,0.00146732,0.001294549,0.0006284237,0.0001750861,0.00186048,0.0006640206,0.0000130334,0.0006947001],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.001920619,"threshold_uncertainty_score":0.007441878,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01245108116759154,"score_gpt":0.2732417503177,"score_spread":0.2607906691501085,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}